In the present study, we aimed to investigate whether BAFFR and BTK protein expression, and BCR signaling activity are already altered at diagnosis, and can be used as a marker to distinguish pSS patients from non-SS sicca patients. This evidence concerns the gene TNFRSF13C and synovial sarcoma.